The use of clinical risk factors enhances the perfomance of BMD in the prediction of hip and osteoporotic fractures in men and women.

  • J.A. Kanis
  • , A. Oden
  • , O. Johnell
  • , H. Johansson
  • , C. de Laet
  • , J. Brown
  • , P. Burckhardt
  • , C. Cooper
  • , C. Christiansen
  • , S. Cummings
  • , J.A. Eisman
  • , S. Fujiwara
  • , C. Gluer
  • , D. Goltzman
  • , D. Hans
  • , M.A. Krieg
  • , A. La Croix
  • , E. McCloskey
  • , D. Mellstrom
  • , L.J. Melton
  • H.A. Pols, J. Reeve, K. Sanders, A.M. Schott, A. Silman, D. Torgerson, T.P. van Staa, N.B. Watts, N. Yoshimura

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1033-1046
Number of pages14
JournalOsteoporosis International
Volume18
Publication statusPublished - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this